News

It is now possible to read the full text of all the 14 articles of the SPRINT-T special issue published on Aging Clinical and Experimental Research!

Tuesday, 14 November, 2017

It is a pleasure to let you know that is now possible to read the full text of each of the 14 articles on the SPRINT-T project published in a special issue of Aging Clinical and Experimental Research in 2017.

THE SPRINT-T ANNUAL MEETING JUST TOOK PLACE IN BASEL SWITZERLAND!!

Friday, 2 June, 2017

The SPRINT-T members gathered at the 2017 annual meeting of the project at the Novartis site (Basel, Switzerland), on June 1st and 2nd, 2017.

This meeting provided an opportunity to present and discuss the progress of the SPRINT-T project and its RCT. During this event it was announced that the clinical trial enrolled its thousandth participant.

Since the aim is still to enroll several other community-dwelling older people across ten European countries, it is still possible to volunteer for participation.

A special issue of AGING CLIN EXP RESEARCH concerning the SPRINTT project has been just published

Sunday, 19 March, 2017

A special issue of the journal Aging Clinical and Experimental Research entirely devoted to the SPRINTT project has been just published.

It includes 14 scientific papers presenting the SPRINTT project background and preliminary results.

Articles are published in the section for Researchers and for Healthcare providers.

THE SPRINT-T TRIAL IS RECRUITING!!!!!!

Friday, 19 February, 2016

What are the main aims of the SPRINTT trial?

The SPRINTT project is the largest European clinical study aimed at investigating whether physical disability may be prevented in older subjects with physical frailty and sarcopenia.

Two interventions will be compared in the SPRINTT trial:

1)       A multicomponent intervention, based on physical activity and nutrition counselling, with support of specific technological devices;

Press release

Thursday, 31 July, 2014

New IMI Project to Avoid Disabilities in Elderly People 

  • Joint research group of academia and pharmaceutical industry targets  physical frailty and sarcopenia (PF&S), a major unmet medical need in ageing societies